What's new

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Feb 13, 2025 - 16:45
 0
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Nimenrix, meningococca...

Next Article

EMEA-003469-PIP01-23

Related Posts

Final list of references supporting the assessment of U...

Mar 12, 2025  0

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Scintimun, besilesomab, Date of authorisation: 11/01/2010, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 20, 2025  0